These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29377150)

  • 1. Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Lepr
    Reifsnyder PC; Ryzhov S; Flurkey K; Anunciado-Koza RP; Mills I; Harrison DE; Koza RA
    Ann N Y Acad Sci; 2018 Apr; 1418(1):106-117. PubMed ID: 29377150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice.
    Teixeira SR; Tappenden KA; Erdman JW
    J Nutr; 2003 Mar; 133(3):673-8. PubMed ID: 12612136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice.
    Chang GR; Chiu YS; Wu YY; Chen WY; Liao JW; Chao TH; Mao FC
    J Pharmacol Sci; 2009 Apr; 109(4):496-503. PubMed ID: 19372632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
    den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S
    Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive.
    Lamming DW; Ye L; Astle CM; Baur JA; Sabatini DM; Harrison DE
    Aging Cell; 2013 Aug; 12(4):712-8. PubMed ID: 23648089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db/db mice.
    Plante E; Menaouar A; Danalache BA; Yip D; Broderick TL; Chiasson JL; Jankowski M; Gutkowska J
    Endocrinology; 2015 Apr; 156(4):1416-28. PubMed ID: 25562615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.
    He J; Quintana MT; Sullivan J; L Parry T; J Grevengoed T; Schisler JC; Hill JA; Yates CC; Mapanga RF; Essop MF; Stansfield WE; Bain JR; Newgard CB; Muehlbauer MJ; Han Y; Clarke BA; Willis MS
    Cardiovasc Diabetol; 2015 Aug; 14():97. PubMed ID: 26242235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.
    Dludla PV; Essop MF; Gabuza KB; Muller CJF; Louw J; Johnson R
    Heart Vessels; 2017 Aug; 32(8):1025-1031. PubMed ID: 28393273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.
    Daltro PS; Alves PS; Castro MF; Azevedo CM; Vasconcelos JF; Allahdadi KJ; de Freitas LA; de Freitas Souza BS; Dos Santos RR; Soares MB; Macambira SG
    BMC Cardiovasc Disord; 2015 Dec; 15():162. PubMed ID: 26631050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes.
    Reifsnyder PC; Flurkey K; Te A; Harrison DE
    Aging (Albany NY); 2016 Nov; 8(11):3120-3130. PubMed ID: 27922820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
    J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice.
    Yang J; Park Y; Zhang H; Xu X; Laine GA; Dellsperger KC; Zhang C
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1850-8. PubMed ID: 19363130
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Burke SJ; Batdorf HM; Burk DH; Noland RC; Eder AE; Boulos MS; Karlstad MD; Collier JJ
    J Diabetes Res; 2017; 2017():8503754. PubMed ID: 29038790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rapamycin schedules in mice on high-fat diet.
    Leontieva OV; Paszkiewicz GM; Blagosklonny MV
    Cell Cycle; 2014; 13(21):3350-6. PubMed ID: 25485580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
    Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
    Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
    Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guan Xin Dan Shen formulation protects
    Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
    Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
    Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.